Ranjan Jayanathan
Known title: Chief Information OfficerCIK: 0001838909
Associated companies
Transaction History
| RDNT | ▼ Sell | Open Market | 65,598 | $4.4M | 8/19/2025 | View on chart |
| RDNT | ▲ Buy | Grant | 11,072 | $0 | 1/8/2025 | View on chart |
| RDNT | ▼ Sell | Open Market | 38,557 | $3.1M | 11/19/2024 | View on chart |
| RDNT | ▲ Buy | Grant | 16,648 | $0 | 1/9/2024 | View on chart |
| RDNT | ▲ Buy | Grant | 26,316 | $0 | 1/3/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
RadNet Q2 Earnings and AI Study News
RadNet received positive marks for its second-quarter testing and diagnostics services earnings. Additionally, a new study suggests DeepHealth AI could help avoid nearly one in five prostate biopsies. These developments provide context for the stock's current position within its 52-week range.
RadNet Q2 Earnings and AI Study News. RadNet received positive marks for its second-quarter testing and diagnostics services earnings. Additionally, a new study suggests DeepHealth AI could help avoid nearly one in five prostate biopsies. These developments provide context for the stock's current position within its 52-week range.